Craig Garthwaite   

 

Home

 

Curriculum Vita



Academic Publications

The Impact of Early Discharge Laws on the Health of Newborns, (with William Evans and Heng Wei), Journal of Health Economics, 2008, 27: 843-870.

The Economic Benefits of Pharmaceutical Innovations: The Case of Cox-2 Inhibitors, American Economic Journal: Applied Economics 2012 4(3): 116-137.

The Doctor Might See You Now: Supply Side Effects of Public Health Insurance Expansions,  American Economic Journal: Economic Policy 2012 4(3): 190-217.

 

Estimating Heterogeneity in the Benefits of Medical Treatment Intensity (with William Evans), The Review of Economics and Statistics, 2012, 94(3): 635-649

Can Celebrity Endorsements Affect Political Outcomes? Evidence from the 2008 U.S. Democratic Presidential Primary (with Timothy J. Moore), The Journal of Law, Economics, and Organization, 2013, 29(2): 355-384.

Giving Mom a Break: The Impact of Higher EITC Payments on Maternal Health (with William Evans), American Economic Journal: Economic Policy, 2014, 6(2): 258-290.

Demand Spillovers, Combative Advertising, and Celebrity Endorsements, American Economic Journal: Applied Economics, 2014, 6(2); 76-104.

Public Health Insurance, Labor Supply, and Employment Lock (with Tal Gross and Matthew Notowidigdo), Quarterly Journal of Economics, 2014, 129(2): 653-696.

The Impacts of the 2008 Economic Downturn on the Health Spending of the Insured (with David Dranove and Christopher Ody), Health Affairs, 2014, 33(8): 1399-1406.

 The Economic Downturn And Its Lingering Effects Reduced Medicare Spending Growth By $4 Billion In 2009–12 (with David Dranove and Christopher Ody), Health Affairs, 2015, 34(8): 1368-1375.

The Market Impacts of Product Patents in Developing Countries: Evidence from India (with Mark Duggan and Aparajita Goyal), American Economic Review, 2016, 106(1): 99-135

Investment Subsidies and the Adoption of Electronic Medical Records in Hospitals, (with David Dranove, Chris Ody, and Bingyang Li), Journal of Health Economics, 2016, 44: 309-319. 

Uncompensated Care Decreased at Hospitals in Medicaid Expansion States But Not At Hospitals in Nonexpansion States (with David Dranove and Christopher Ody), Health Affairs, 2016, 35(8): 1471-1479.

The White/Black Educational Gap, Stalled Progress, and the Long Term Consequences of the Emergence of Crack Cocaine Markets, (with William Evans and Timothy J. Moore), The Review of Economics and Statistics, 2016, 98(5): 832–847

 

Early Impact of the Affordable Care Act on Emergency Department Use, (with John Graves, Tal Gross, and Matthew Notowidigdo), Annals of Internal Medicine, Feb 7, 2017, 166(3):172-179

How Do Hospitals Respond to Negative Financial Shocks? The Impact of the 2008 Stock Market Crash (with David Dranove and Christopher Ody), The RAND Journal of Economics, 2017, 48(2): 485–525.

Success and Failure in the Insurance Exchanges (with John Graves), New England Journal of Medicine, March 9, 2017, 376(10):907-910

The Economics of Indication Based Pricing (with Amitabh Chandra), New England Journal of Medicine, July 2017, 377(2):103-106.

Hospitals as Insurers of Last Resort, (with Tal Gross and Matthew Notowidigdo), American Economic Journal: Applied Economics, 2018, 10(1): 1-39.

The CVS–Aetna Merger: Another Large Bet on the Changing U.S. Health Care Landscape (with Austin Frakt), Annals of Internal Medicine, January 9, 2018.

The Orphan Drug Act at 35: Observations and an Outlook for the Twenty-First Century, (with Nicholas Bagley, Benjamin Berger, Amitabh Chandra, and Ariel D. Stern) in Innovation Policy and the Economy, 2018, Volume 19, pages 97-137, National Bureau of Economic Research, Inc.

Characterizing the Drug Development Pipeline for Precision Medicine, (with Chandra, Amitabh, Garthwaite, Craig and Stern, Ariel Dora Stern), Economic Dimensions of Personalized and Precision Medicine, 2018, National Bureau of Economic Research, Inc.

It’s Time to Reform the Orphan Drug Act (with Nicholas Bagley, Amitabh Chandra, and Ariel D. Stern), NEJM Catalyst, Dec 19, 2018.

Economic Principles for Medicare Reform (with Amitabh Chandra), ANNALS of the American Academy of Political and Social Science, volume 686, 2019.

“All Medicaid Expansions Are Not Created Equal: The Geography and Targeting of the Affordable Care Act,” forthcoming Brookings Papers on Economic Activity, August 2019 (with John Graves, Tal Gross, Zeynal Karaca, Victoria Marone, and Matthew Notowidigdo)

“The Economics of Medicare for All,” book chapter in Maintaining the Strength of American Capitalism published by the Aspen Economic Strategy Group, eds. Melissa Kearney and Amy Ganz, December 2019.

“Insurance access and demand response: Price and welfare implications,” (with David Dranove and David Besanko), Journal of Health Economics, 2020, 73.

 

Congressional Testimony

 

Testimony, United States House of Representatives, 2018

·       House Judiciary Committee, Subcommittee on Regulatory Reform, Commercial and Antitrust Law: “Competition in the Pharmaceutical Supply Chain: The Proposed Merger of CVS Health and Aetna”

Testimony, United States House of Representatives, 2019

·       House Judiciary Committee, Subcommittee on Regulatory Reform, Commercial and Antitrust Law: “Diagnosing the Problem: Exploring the Effects of Consolidation and Anticompetitive Conduct in Health Care Markets”

Testimony, United States Senate, 2019

·       Senate Judiciary Committee, Subcommittee on Antirust, Competition Policy, and Consumer Rights: “Your Doctor/Pharmacist/Insurer Will See You Now: Competitive Implications of Vertical Consolidation in the Healthcare Industry”

 

Testimony, United States House of Representatives, 2019

·       House Education and Labor Committee, Subcommittee on Health, Education, Labor and Pensions: “Making Health Care More Affordable: Lowering Drug Prices and Increasing Transparency”

 

Working Papers

“Who Profits From Amateurism: Rent-Sharing in Modern College Sports,” NBER Working Paper #27734 (with Jordan Keener Matthew J. Notowidigdo Nicole F. Ozminkowski)

“Endogenous Quality Investments in the US Hospital Market,” NBER Working Paper #27440 (with Chris Ody and Amanda Starc)

“The Impact of Private Contracting on Healthcare for the Old and Sick: Evidence from California’s Medicaid Program” (with Mark Duggan and Adelina Wang)

“Reinsuring the Insurers of Last Resort” (with Chris Ody and David Dranove)

“Expected Profits and The Scientific Novelty of Innovation,” NBER Working Paper #27093 \, (with David Dranove and Manuel Hermosilla)

“The Opportunities and Limitations of Monopsony Power in Healthcare: Evidence from the United States and Canada,” July 2019 (with Jillian Chown, David Dranove, and Jordan Keener)

Guns and Violence: The Enduring Impact of Crack Cocaine Markets on Young Black Males, NBER Working Paper #24819, (with Bill Evans and Timothy J. Moore)

Pharmaceutical Profits and the Social Value of Innovation, NBER Working Paper #20212, (with David Dranove and Manuel Hermosilla)

 

Permanent Working Papers

 

The Effect of In-Utero Conditions on Long Term Health:  Evidence from the 1918 Spanish Flu Pandemic, May 2008 (First Draft: July, 2007)

 

Other Publications

A Floor-and-Trade Proposal to Improve the Delivery of CharityCare Services by U.S. Nonprofit Hospitals, (with David Dranove and Christopher Ody), The Hamilton Project Discussion Paper Series, 2015.

 

Empirical Evidence on the Value of Pharmaceuticals, (with Mark Duggan), in The [Oxford]

Handbook of the Economics of the Biopharmaceutical Industry, 2012.

 

Starbucks: A Story of Growth, (with Jen Brown and Meghan Busse), 2011. Kellogg Case #5-211-259.

The Global Aircraft Manufacturing Industry, 2002-2011 (with Jen Brown), 2012.  Kellogg Case #5-312-505.

 

Sovaldi: Pricing a Breakthrough Drug, (with Meghan Busse), 2015, Kellogg Case.